*April 2024*
Video: Dr. Joseph Treat from Fox Chase Cancer Center discusses the LP-300 clinical trial regarding EGFR+ NSCLC in the never smoker population. Watch video here.
The EGFR Resisters is a global community of patients and caregivers impacted by EGFR-positive lung cancer. We’re here to share knowledge, offer support and collaborate to drive progress in research and care. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.